WallStSmart

Dynex Capital Inc (DX)vsWelltower Inc (WELL)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 81267% more annual revenue ($13.79B vs $16.95M). WELL leads profitability with a 12.1% profit margin vs -293.5%. DX appears more attractively valued with a PEG of 0.71. WELL earns a higher WallStSmart Score of 57/100 (C).

DX

Buy

55

out of 100

Grade: C-

Growth: 8.3Profit: 3.0Value: 5.7Quality: 2.5
Piotroski: 2/9Altman Z: -0.72

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DX.

WELLSignificantly Overvalued (-81.0%)

Margin of Safety

-81.0%

Fair Value

$135.40

Current Price

$244.95

$109.55 premium

UndervaluedFair: $135.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DX4 strengths · Avg: 9.5/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
234.8%10/10

Revenue surging 234.8% year-over-year

EPS GrowthGrowth
92.3%10/10

Earnings expanding 92.3% YoY

PEG RatioValuation
0.718/10

Growing faster than its price suggests

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
38.4%10/10

Revenue surging 38.4% year-over-year

Market CapQuality
$172.10B9/10

Large-cap with strong market position

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

Areas to Watch

DX4 concerns · Avg: 2.5/10
P/E RatioValuation
38.6x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
-0.722/10

Distress zone — elevated risk

Profit MarginProfitability
-293.5%1/10

Currently unprofitable

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
99.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DX

The strongest argument for DX centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 234.8% demonstrates continued momentum. PEG of 0.71 suggests the stock is reasonably priced for its growth.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 38.4% demonstrates continued momentum.

Bear Case : DX

The primary concerns for DX are P/E Ratio, Piotroski F-Score, Altman Z-Score. Debt-to-equity of 7.93 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 99.4x leaves little room for execution misses.

Key Dynamics to Monitor

DX profiles as a hypergrowth stock while WELL is a growth play — different risk/reward profiles.

DX carries more volatility with a beta of 0.98 — expect wider price swings.

DX is growing revenue faster at 234.8% — sustainability is the question.

WELL generates stronger free cash flow (449M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 55/100) and 38.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dynex Capital Inc

REAL ESTATE · REIT - MORTGAGE · USA

Dynex Capital, Inc., a mortgage real estate investment trust, invests in Mortgage-Backed Securities (MBS) on a leveraged basis in the United States. The company is headquartered in Glen Allen, Virginia.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?